United States Biotechnology & Medical Research

Xeris Biopharma Holdings Inc (XERS)

Track

Over the past 90 days, Xeris Biopharma Holdings Inc. insiders have executed 18 transactions, all of which were sales totaling approximately $3.96 million. These divestments occurred following a 47.6% stock price increase and a positive earnings report in May. No insider purchases were recorded during this period.
Ticker: XERS Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Xeris Biopharma Holdings Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Pieper Steven
See Remarks
1 sale — total 100,000 USD
Planned sale 7 Jul 2026
Value US$4,942,074.98 | Price 330.56 | Shares 63,142
Proposed sale 7 Jul 2026
Value US$4,902,987.09 | Price 62.25 | Shares 6,009
Planned sale 6 Jul 2026
Value US$100,000.00 | Price 8.50 | Shares 1,000
Proposed sale 6 Jul 2026
Value US$100,000.00 | Price 8.28 | Shares 1,000
Planned sale 1 Jul 2026
Value US$100,000.00 | Price 8.03 | Shares 1,000
Planned sale 1 Jul 2026
Value US$100,000.00 | Price 8.03 | Shares 1,000
Proposed sale 1 Jul 2026
Value US$395,984.16 | Price 7.92 | Shares 49,998
Proposed sale 1 Jul 2026
Value US$950,400.00 | Price 7.92 | Shares 120,000
Planned sale 4 Jun 2026
Value US$97,507.20 | Price 6.09 | Shares 16,000
Planned sale 4 Jun 2026
Value US$91,422.00 | Price 6.09 | Shares 15,000
Planned sale 4 Jun 2026
Value US$121,886.00 | Price 6.09 | Shares 20,000
Proposed sale 4 Jun 2026
Value US$117,800.00 | Price 5.89 | Shares 20,000
Proposed sale 4 Jun 2026
Value US$88,350.00 | Price 5.89 | Shares 15,000
Proposed sale 4 Jun 2026
Value US$94,240.00 | Price 5.89 | Shares 16,000
Planned sale 3 Jun 2026
Value US$91,432.95 | Price 5.90 | Shares 15,500
Proposed sale 3 Jun 2026
Value US$93,000.00 | Price 6.00 | Shares 15,500
Planned sale 1 Jun 2026
Value US$100,982.02 | Price 6.06 | Shares 16,667
Planned sale 1 May 2026
Value US$103,805.41 | Price 6.23 | Shares 16,667
Planned sale 1 Apr 2026
Value US$99,858.66 | Price 5.99 | Shares 16,667
Planned sale 30 Mar 2026
Value US$60,035.53 | Price 5.54 | Shares 10,834
Proposed sale 30 Mar 2026
Value US$58,503.60 | Price 5.40 | Shares 10,834
Planned sale 2 Mar 2026
Value US$706.00 | Price 7.06 | Shares 100
Planned sale 2 Mar 2026
Value US$103,379.74 | Price 6.24 | Shares 16,567
Proposed sale 2 Mar 2026
Value US$408,008.16 | Price 6.12 | Shares 66,668
Planned sale 2 Feb 2026
Value US$124,147.48 | Price 7.45 | Shares 16,667
Planned sale 8 Jan 2026
Value US$120,000.00 | Price 8.00 | Shares 15,000
Proposed sale 8 Jan 2026
Value US$432,600.00 | Price 7.21 | Shares 60,000
Planned sale 5 Jan 2026
Value US$176,256.88 | Price 7.08 | Shares 24,907
Planned sale 2 Jan 2026
Value US$123,775.81 | Price 7.43 | Shares 16,667
Proposed sale 19 Dec 2025
Value US$977,033.75 | Price 7.22 | Shares 135,402
Sale 19 Dec 2025
Value US$977,019.32 | Price 7.22 | Shares 135,400
Planned sale 12 Dec 2025
Value US$106,414.50 | Price 7.09 | Shares 15,000
Proposed sale 12 Dec 2025
Value US$105,150.00 | Price 7.01 | Shares 15,000
Planned sale 1 Dec 2025
Value US$116,780.67 | Price 7.01 | Shares 16,667
Planned sale 13 Nov 2025
Value US$173,401.59 | Price 7.46 | Shares 23,242
Proposed sale 13 Nov 2025
Value US$365,450.91 | Price 7.59 | Shares 48,149
Planned sale 11 Nov 2025
Value US$123,295.80 | Price 7.40 | Shares 16,667
Proposed sale 11 Nov 2025
Value US$514,676.96 | Price 7.72 | Shares 66,668
Planned sale 11 Sep 2025
Value US$119,610.40 | Price 7.72 | Shares 15,500
Proposed sale 11 Sep 2025
Value US$121,055.00 | Price 7.81 | Shares 15,500
Sale 28 Aug 2025
Value US$334,515.45 | Price 7.92 | Shares 42,232
Proposed sale 28 Aug 2025
Value US$334,511.23 | Price 7.92 | Shares 42,232
Sale 13 Aug 2025
Value US$786,459.25 | Price 7.32 | Shares 107,500
Proposed sale 13 Aug 2025
Value US$786,451.77 | Price 7.32 | Shares 107,500
Sale 12 Aug 2025
Value US$309,225.75 | Price 7.28 | Shares 42,500
Proposed sale 12 Aug 2025
Value US$309,225.75 | Price 7.28 | Shares 42,500
Buy 13 Jun 2025
Value US$109,475.00 | Price 4.38 | Shares 25,000
Proposed sale 9 May 2025
Value US$277,668.30 | Price 4.90 | Shares 56,667
Sale 20 Mar 2025
Value US$217,244.00 | Price 5.43 | Shares 40,000
Proposed sale 20 Mar 2025
Value US$205,600.00 | Price 5.14 | Shares 40,000
Buy 12 Aug 2024
Value US$10,147.01 | Price 2.25 | Shares 4,515
Buy 9 Aug 2024
Value US$10,134.02 | Price 2.37 | Shares 4,285
Buy 10 May 2024
Value US$10,314.00 | Price 1.91 | Shares 5,400
Buy 10 May 2024
Value US$10,314.00 | Price 1.91 | Shares 5,400
Buy 14 Mar 2024
Value US$9,720.00 | Price 2.16 | Shares 4,500
Buy 27 Nov 2023
Value US$10,098.00 | Price 1.87 | Shares 5,400
Buy 20 Nov 2023
Value US$54,600.00 | Price 1.95 | Shares 28,000
Buy 20 Nov 2023
Value US$9,954.40 | Price 1.84 | Shares 5,410
Buy 17 Nov 2023
Value US$50,399.62 | Price 1.64 | Shares 30,769
Buy 16 Nov 2023
Value US$9,815.00 | Price 1.51 | Shares 6,500
Buy 14 Nov 2023
Value US$10,057.59 | Price 1.58 | Shares 6,370
Buy 9 Aug 2023
Value US$23,794.00 | Price 2.38 | Shares 10,000
Buy 13 Dec 2022
Value US$29,000.00 | Price 1.45 | Shares 20,000
Buy 12 May 2022
Value US$140,380.00 | Price 1.40 | Shares 100,000
Planned sale 22 Feb 2022
Value US$27,158.29 | Price 2.42 | Shares 11,228
Buy 15 Nov 2021
Value US$45,664.00 | Price 2.28 | Shares 20,000
Buy 12 Nov 2021
Value US$126,000.00 | Price 2.10 | Shares 60,000
Buy 11 Nov 2021
Value US$415,760.00 | Price 2.08 | Shares 200,000
Buy 11 Nov 2021
Value US$83,500.00 | Price 2.09 | Shares 40,000
Buy 10 Nov 2021
Value US$49,917.50 | Price 2.00 | Shares 25,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-07 2026-07-07 PlS Planned sale
3.7
Pieper Steven

See Remarks

Officer
63,142 -45.0%
330.56
US$4,942,075 		63,142 -45.0% 330.56 US$4,942,075
2026-07-07 2026-07-07 PrS Proposed sale
3.7
STEVEN PIEPER

Officer

Officer
6,009
62.25
US$4,902,987 		6,009 62.25 US$4,902,987
2026-07-07 2026-07-06 PlS Planned sale
3.7
Pieper Steven

See Remarks

Officer
27,903 +11.7%
225.27
US$3,232,862 		27,903 +11.7% 225.27 US$3,232,862
2026-07-06 2026-07-06 PrS Proposed sale
3.7
STEVEN PIEPER

Officer

Officer
1,000
8.28
US$100,000 		1,000 8.28 US$100,000
2026-07-02 2026-07-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
1,000 -1.4%
8.03
US$100,000 		1,000 -1.4% 8.03 US$100,000
2026-07-02 2026-07-01 PlS Planned sale
3.4
McCulloch Kevin

See Remarks

Officer
1,000 -5.1%
8.03
US$100,000 		1,000 -5.1% 8.03 US$100,000
2026-07-01 2026-07-01 PrS Proposed sale
3.1
BETH HECHT

Officer

Officer
49,998
7.92
US$395,984 		49,998 7.92 US$395,984
2026-07-01 2026-07-01 PrS Proposed sale
3.4
KEVIN MCCULLOCH

Officer

Officer
120,000
7.92
US$950,400 		120,000 7.92 US$950,400
2026-06-05 2026-06-04 PlS Planned sale
BORMANN-KENNEDY BARBARA-JEAN ANNE
Non-Executive Director
16,000 -11.2%
6.09
US$97,507 		16,000 -11.2% 6.09 US$97,507
2026-06-05 2026-06-04 PlS Planned sale
3.2
JOHNSON JOHN
Non-Executive Director
15,000 -2.1%
6.09
US$91,422 		15,000 -2.1% 6.09 US$91,422
2026-06-05 2026-06-04 PlS Planned sale
2.7
HALKUFF DAWN
Non-Executive Director
20,000 -17.4%
6.09
US$121,886 		20,000 -17.4% 6.09 US$121,886
2026-06-04 2026-06-04 PrS Proposed sale
2.7
DAWN HALKUFF

Director

Non-Executive Director
20,000
5.89
US$117,800 		20,000 5.89 US$117,800
2026-06-04 2026-06-04 PrS Proposed sale
3.2
JOHN H JOHNSON

Director

Non-Executive Director
15,000
5.89
US$88,350 		15,000 5.89 US$88,350
2026-06-04 2026-06-04 PrS Proposed sale
Barbara-Jean Bormann-Kennedy

Director

Non-Executive Director
16,000
5.89
US$94,240 		16,000 5.89 US$94,240
2026-06-05 2026-06-03 PlS Planned sale
3.3
PERSKY MARLA
Non-Executive Director
15,500 -10.9%
5.90
US$91,433 		15,500 -10.9% 5.90 US$91,433
2026-06-03 2026-06-03 PrS Proposed sale
3.3
MARLA PERSKY

Director

Non-Executive Director
15,500
6.00
US$93,000 		15,500 6.00 US$93,000
2026-06-02 2026-06-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.4%
6.06
US$100,982 		16,667 -1.4% 6.06 US$100,982
2026-05-01 2026-05-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.4%
6.23
US$103,805 		16,667 -1.4% 6.23 US$103,805
2026-04-03 2026-04-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.4%
5.99
US$99,859 		16,667 -1.4% 5.99 US$99,859
2026-04-01 2026-03-30 PlS Planned sale
Brady James Aloysius
Non-Executive Director
10,834 -10.8%
5.54
US$60,036 		10,834 -10.8% 5.54 US$60,036
2026-03-30 2026-03-30 PrS Proposed sale
JAMES BRADY

Director

Non-Executive Director
10,834
5.40
US$58,504 		10,834 5.40 US$58,504
2026-03-04 2026-03-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
100 -0.0%
7.06
US$706 		100 -0.0% 7.06 US$706
2026-03-04 2026-03-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,567 -1.3%
6.24
US$103,380 		16,567 -1.3% 6.24 US$103,380
2026-03-02 2026-03-02 PrS Proposed sale
3.1
BETH HECHT

Officer

Officer
66,668
6.12
US$408,008 		66,668 6.12 US$408,008
2026-02-02 2026-02-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.3%
7.45
US$124,147 		16,667 -1.3% 7.45 US$124,147
2026-01-09 2026-01-08 PlS Planned sale
3.4
McCulloch Kevin

See Remarks

Officer
15,000 -0.9%
8.00
US$120,000 		15,000 -0.9% 8.00 US$120,000
2026-01-08 2026-01-08 PrS Proposed sale
3.4
KEVIN MCCULLOCH

Officer

Officer
60,000
7.21
US$432,600 		60,000 7.21 US$432,600
2026-01-06 2026-01-05 PlS Planned sale
3.8
Shannon John Patrick Jr

See Remarks

Executive Director
24,907 -0.9%
7.08
US$176,257 		24,907 -0.9% 7.08 US$176,257
2026-01-05 2026-01-02 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.3%
7.43
US$123,776 		16,667 -1.3% 7.43 US$123,776
2025-12-19 2025-12-19 PrS Proposed sale
3.2
JOHN H JOHNSON

Director

Non-Executive Director
135,402
7.22
US$977,034 		135,402 7.22 US$977,034
2025-12-19 2025-12-19 S Sale
3.2
JOHNSON JOHN
Non-Executive Director
135,400 -16.2%
7.22
US$977,019 		135,400 -16.2% 7.22 US$977,019
2025-12-15 2025-12-12 PlS Planned sale
BORMANN-KENNEDY BARBARA-JEAN ANNE
Non-Executive Director
15,000 -9.5%
7.09
US$106,414 		15,000 -9.5% 7.09 US$106,414
2025-12-12 2025-12-12 PrS Proposed sale
BARBARA-JEAN A BORMANN-KENNEDY

Director

Non-Executive Director
15,000
7.01
US$105,150 		15,000 7.01 US$105,150
2025-12-02 2025-12-01 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.2%
7.01
US$116,781 		16,667 -1.2% 7.01 US$116,781
2025-11-17 2025-11-13 PlS Planned sale
3.8
Shannon John Patrick Jr

See Remarks

Executive Director
23,242 -0.9%
7.46
US$173,402 		23,242 -0.9% 7.46 US$173,402
2025-11-13 2025-11-13 PrS Proposed sale
3.8
JOHN SHANNON

Director; Officer

Executive Director
48,149
7.59
US$365,451 		48,149 7.59 US$365,451
2025-11-13 2025-11-11 PlS Planned sale
3.1
Hecht Beth

See Remarks

Officer
16,667 -1.2%
7.40
US$123,296 		16,667 -1.2% 7.40 US$123,296
2025-11-12 2025-11-11 PrS Proposed sale
3.1
BETH HECHT

Officer

Officer
66,668
7.72
US$514,677 		66,668 7.72 US$514,677
2025-09-12 2025-09-11 PlS Planned sale
3.3
PERSKY MARLA
Non-Executive Director
15,500 -9.8%
7.72
US$119,610 		15,500 -9.8% 7.72 US$119,610
2025-09-11 2025-09-11 PrS Proposed sale
3.3
MARLA PERSKY

Director

Non-Executive Director
15,500
7.81
US$121,055 		15,500 7.81 US$121,055
2025-08-29 2025-08-28 S Sale
3.0
SHERMAN JEFFREY W
Non-Executive Director
42,232 -16.2%
7.92
US$334,515 		42,232 -16.2% 7.92 US$334,515
2025-08-28 2025-08-28 PrS Proposed sale
3.0
JEFFREY SHERMAN

Director

Non-Executive Director
42,232
7.92
US$334,511 		42,232 7.92 US$334,511
2025-08-15 2025-08-13 S Sale
3.2
JOHNSON JOHN
Non-Executive Director
107,500 -11.4%
7.32
US$786,459 		107,500 -11.4% 7.32 US$786,459
2025-08-13 2025-08-13 PrS Proposed sale
3.2
JOHN H JOHNSON

Director

Non-Executive Director
107,500
7.32
US$786,452 		107,500 7.32 US$786,452
2025-08-13 2025-08-12 S Sale
2.7
HALKUFF DAWN
Non-Executive Director
42,500 -27.0%
7.28
US$309,226 		42,500 -27.0% 7.28 US$309,226
2025-08-12 2025-08-12 PrS Proposed sale
2.7
DAWN HALKUFF

Director

Non-Executive Director
42,500
7.28
US$309,226 		42,500 7.28 US$309,226
2025-06-16 2025-06-13 B Purchase
3.4
McCulloch Kevin

See Remarks

Officer
25,000 +1.5%
4.38
US$109,475 		25,000 +1.5% 4.38 US$109,475
2025-05-09 2025-05-09 PrS Proposed sale
Fairley Ricki Louise

Director

Non-Executive Director
56,667
4.90
US$277,668 		56,667 4.90 US$277,668
2025-03-21 2025-03-20 S Sale
3.1
Hecht Beth

See Remarks

Officer
40,000 -2.9%
5.43
US$217,244 		40,000 -2.9% 5.43 US$217,244
2025-03-20 2025-03-20 PrS Proposed sale
3.1
Hecht Beth

Officer

Officer
40,000
5.14
US$205,600 		40,000 5.14 US$205,600
2024-08-13 2024-08-12 B Purchase
2.6
Schmid John P.
Non-Executive Director
4,515 +21.8%
2.25
US$10,147 		4,515 +21.8% 2.25 US$10,147
2024-08-12 2024-08-09 B Purchase
2.6
Schmid John P.
Non-Executive Director
4,285 +26.1%
2.37
US$10,134 		4,285 +26.1% 2.37 US$10,134
2024-05-10 2024-05-10 B Purchase
2.6
Schmid John P.
Non-Executive Director
5,400 +49.1%
1.91
US$10,314 		5,400 +49.1% 1.91 US$10,314
2024-05-10 2024-05-10 B Purchase
2.6
Schmid John P.
Non-Executive Director
5,400 +49.1%
1.91
US$10,314 		5,400 +49.1% 1.91 US$10,314
2024-03-14 2024-03-14 B Purchase
2.6
Schmid John P.
Non-Executive Director
4,500 +69.2%
2.16
US$9,720 		4,500 +69.2% 2.16 US$9,720
2023-11-29 2023-11-27 B Purchase
3.0
SHERMAN JEFFREY W
Non-Executive Director
5,400 +inf%
1.87
US$10,098 		5,400 +inf% 1.87 US$10,098
2023-11-21 2023-11-20 B Purchase
3.7
Pieper Steven

See Remarks

Officer
28,000 +2.4%
1.95
US$54,600 		28,000 +2.4% 1.95 US$54,600
2023-11-21 2023-11-20 B Purchase
2.7
HALKUFF DAWN
Non-Executive Director
5,410 +inf%
1.84
US$9,954 		5,410 +inf% 1.84 US$9,954
2023-11-17 2023-11-17 B Purchase
3.8
Shannon John Patrick Jr

See Remarks

Officer
30,769 +2.2%
1.64
US$50,400 		30,769 +2.2% 1.64 US$50,400
2023-11-17 2023-11-16 B Purchase
2.6
Schmid John P.
Non-Executive Director
6,500 +inf%
1.51
US$9,815 		6,500 +inf% 1.51 US$9,815
2023-11-15 2023-11-14 B Purchase
3.3
PERSKY MARLA
Non-Executive Director
6,370 +inf%
1.58
US$10,058 		6,370 +inf% 1.58 US$10,058
2023-08-09 2023-08-09 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
10,000 +0.4%
2.38
US$23,794 		10,000 +0.4% 2.38 US$23,794
2022-12-14 2022-12-13 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
20,000 +1.3%
1.45
US$29,000 		20,000 +1.3% 1.45 US$29,000
2022-05-13 2022-05-12 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
100,000 +7.1%
1.40
US$140,380 		100,000 +7.1% 1.40 US$140,380
2022-02-24 2022-02-22 PlS Planned sale
PRESTRELSKI STEVEN

Chief Scientific Officer

Officer
11,228 -1.9%
2.42
US$27,158 		11,228 -1.9% 2.42 US$27,158
2021-11-16 2021-11-15 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
20,000 +148.9%
2.28
US$45,664 		20,000 +148.9% 2.28 US$45,664
2021-11-12 2021-11-12 B Purchase
3.8
Shannon John Patrick Jr

See Remarks

Officer
60,000 +19.7%
2.10
US$126,000 		60,000 +19.7% 2.10 US$126,000
2021-11-12 2021-11-11 B Purchase
3.8
Edick Paul R

See Remarks

Executive Director
200,000 +32.9%
2.08
US$415,760 		200,000 +32.9% 2.08 US$415,760
2021-11-12 2021-11-11 B Purchase
3.8
Shannon John Patrick Jr

See Remarks

Officer
40,000 +15.2%
2.09
US$83,500 		40,000 +15.2% 2.09 US$83,500
2021-11-12 2021-11-10 B Purchase
3.7
Pieper Steven

See Remarks

Officer
25,000 +15.8%
2.00
US$49,918 		25,000 +15.8% 2.00 US$49,918
Explore more

More insider trading research around Xeris Biopharma Holdings Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America